Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Adenocarcinoma (ductal Adenocarcinoma)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04117087
What this trial is testing

Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic Cancer

Who this might be right for
Colorectal CancerPancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27
Not applicableStudy completedNCT04133155
What this trial is testing

Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic Cancer

Who this might be right for
Pancreatic CancerMetastatic Pancreatic Cancer
Asan Medical Center 103
Early research (Phase 1)Study completedNCT04581343
What this trial is testing

A Phase 1B Study of Canakinumab, Spartalizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer (PC) Patients

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Pancreatic Cancer Action Network 10
Early research (Phase 1)WithdrawnNCT06206876
What this trial is testing

FL118 for Treating Patients With Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Advanced Pancreatic Ductal AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal Adenocarcinoma+5 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT02289898
What this trial is testing

Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Cancer
OncoMed Pharmaceuticals, Inc. 207
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07678593
What this trial is testing

GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation

Who this might be right for
Advanced Solid Tumors CancerPancreatic Ductal AdenocarcinomaRAS Mutation
Genfleet Therapeutics (Shanghai) Inc. 222
Testing effectiveness (Phase 2)Active Not RecruitingNCT02498613
What this trial is testing

Cediranib in Combination With Olaparib in Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+23 more
National Cancer Institute (NCI) 122
Testing effectiveness (Phase 2)Study completedNCT00902291
What this trial is testing

AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer

Who this might be right for
Carcinoma, Pancreatic DuctalPancreatic CancerPancreatic Disease
Astellas Pharma Inc 205
Testing effectiveness (Phase 2)Study completedNCT02178709
What this trial is testing

A Phase II Study of Neoadjuvant FOLFIRINOX

Who this might be right for
Resectable Pancreatic Ductal Adenocarcinoma
Indiana University 48
Large-scale testing (Phase 3)Ended earlyNCT04329949
What this trial is testing

Study of Relacorilant in Combination With Nab-Paclitaxel in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Corcept Therapeutics 43
Early research (Phase 1)Study completedNCT04580485
What this trial is testing

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

Who this might be right for
Ovarian CancerBladder CancerNon Small Cell Lung Cancer+8 more
Incyte Corporation 54
Not applicableStudy completedNCT06461598
What this trial is testing

Signature for Precise Chemosensitivity Prediction in PDAC

Who this might be right for
Pancreatic Cancer
Ruijin Hospital 365
Testing effectiveness (Phase 2)Looking for participantsNCT06850623
What this trial is testing

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
EXACT Therapeutics AS 25
Not applicableEnded earlyNCT04400903
What this trial is testing

Monitoring Heart Rate Variability for the Early Detection of Pancreatic Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaStage I Pancreatic Cancer AJCC v8Stage IA Pancreatic Cancer AJCC v8+1 more
OHSU Knight Cancer Institute 110
Not applicableNot Yet RecruitingNCT06616688
What this trial is testing

Innovative Therapeutic Treatments to Inhibit Perineural Invasion in Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
IRCCS San Raffaele 50
Testing effectiveness (Phase 2)Looking for participantsNCT07114861
What this trial is testing

The KN510713 Study in Combination With mFOLFIRINOX

Who this might be right for
Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
New Cancer Cure-Bio Co.,Ltd. 30
Large-scale testing (Phase 3)Study completedNCT04935359
What this trial is testing

Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Novartis Pharmaceuticals 511
Early research (Phase 1)Study completedNCT04672434
What this trial is testing

Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 48
Not applicableEnrolling By InvitationNCT06157671
What this trial is testing

The LINFU® U.S. Registry for the Detection of Asymptomatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaPancreatic Intraepithelial Neoplasia
Adenocyte, LLC 1,000
Not applicableStudy completedNCT06947395
What this trial is testing

Clinical Validation of a Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer (VERIFI)

Who this might be right for
Cancer of the PancreasPancreatic CancerPancreas Neoplasms+2 more
Immunovia, Inc. 386
Next Page